Intuitive Surgical, Inc. $ISRG Shares Sold by Corient Private Wealth LP

Corient Private Wealth LP lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 329,718 shares of the medical equipment provider’s stock after selling 7,045 shares during the quarter. Corient Private Wealth LP’s holdings in Intuitive Surgical were worth $131,122,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in ISRG. Motiv8 Investments LLC purchased a new position in Intuitive Surgical during the 4th quarter worth approximately $34,000. Main Street Group LTD purchased a new stake in shares of Intuitive Surgical during the first quarter worth $30,000. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth $39,000. Vermillion Wealth Management Inc. grew its stake in Intuitive Surgical by 58.1% in the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after purchasing an additional 25 shares in the last quarter. Finally, High Note Wealth LLC increased its position in Intuitive Surgical by 50.0% in the 4th quarter. High Note Wealth LLC now owns 69 shares of the medical equipment provider’s stock worth $39,000 after purchasing an additional 23 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Mark Brosius sold 77 shares of the company’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $375.57, for a total value of $28,918.89. Following the completion of the transaction, the executive vice president directly owned 881 shares in the company, valued at approximately $330,877.17. This represents a 8.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 400 shares of the stock in a transaction on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the transaction, the director owned 251 shares of the company’s stock, valued at approximately $95,129. This trade represents a 61.44% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 11,281 shares of company stock valued at $4,484,224 over the last 90 days. Company insiders own 0.60% of the company’s stock.

Intuitive Surgical Stock Up 2.4%

Shares of NASDAQ:ISRG opened at $369.15 on Friday. The stock has a market cap of $130.41 billion, a price-to-earnings ratio of 42.29, a PEG ratio of 2.72 and a beta of 1.47. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88. The business’s 50 day moving average is $376.27 and its 200 day moving average is $423.82.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The business had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same period last year, the business posted $1.81 earnings per share. The business’s revenue for the quarter was up 18.4% on a year-over-year basis. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on ISRG shares. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. Leerink Partners reduced their price objective on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a research report on Friday, July 17th. Robert W. Baird lowered their price target on Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, July 17th. Wells Fargo & Company reissued an “overweight” rating and issued a $487.00 price objective (down from $654.00) on shares of Intuitive Surgical in a research report on Friday, July 17th. Finally, Raymond James Financial reissued an “outperform” rating and set a $483.00 target price (down from $577.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Twenty-two investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $508.68.

About Intuitive Surgical

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company’s principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.